Skip to content

Clinical trials

Observational Inflammatory Bowel Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Observational Country / region: Italy Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20151
20162
20181
20191
20203
20215
20223
20233
20248
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10
Completed9
Unknown status9
Active, not recruiting5
Not yet recruiting2
Terminated1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione Policlinico Universitario Agostino Gemelli IRCCS7
IRCCS Azienda Ospedaliero-Universitaria di Bologna6
IRCCS San Raffaele4
AbbVie2
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria2
Casa di Cura Dott. Pederzoli1
DiaSorin Inc.1
Federico II University1
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1
Hospital of Prato1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases37
Colitis, Ulcerative10
Crohn Disease10
Colorectal Neoplasms3
Gastrointestinal Diseases2
Irritable Bowel Syndrome2
Malnutrition2
Arthritis, Psoriatic1
Avoidant Restrictive Food Intake Disorder1
COVID-191

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.